This study investigated a series of matched primary and lymph node metastasis breast cancer tumors to demonstrate whether the expression of the CXCR4 and CCR7 chemokine receptors, along with expression of EGFR, predicts increased risk of metastasis and mortality. Here, CXCR4 is linked to metastatic malignant neoplasm in the lymph nodes.